RAB31

Chr 18

RAB31, member RAS oncogene family

Also known as: Rab22B

RAB31 encodes a small GTPase that regulates intracellular membrane trafficking, including transport between the Golgi apparatus, trans-Golgi network, and endosomes, as well as insulin-stimulated glucose transporter translocation and receptor internalization. Mutations in RAB31 cause autosomal recessive intellectual developmental disorder with microcephaly, seizures, and limb malformations. The gene shows tolerance to loss-of-function variants (pLI 0.001), consistent with the recessive inheritance pattern observed in affected individuals.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
16
Pubs (1 yr)
103
P/LP submissions
0%
P/LP missense
1.12
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryRAB31
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
98 unique Pathogenic / Likely Pathogenic· 26 VUS of 136 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.12LOEUF
pLI 0.001
Z-score 1.30
OE 0.57 (0.311.12)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.29Z-score
OE missense 0.65 (0.530.79)
69 obs / 106.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.57 (0.311.12)
00.351.4
Missense OE0.65 (0.530.79)
00.61.4
Synonymous OE0.62
01.21.6
LoF obs/exp: 6 / 10.5Missense obs/exp: 69 / 106.5Syn Z: 1.81
DN
0.85top 5%
GOF
0.80top 10%
LOF
0.2091th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

136 submitted variants in ClinVar

Classification Summary

Pathogenic96
Likely Pathogenic2
VUS26
Benign1
96
Pathogenic
2
Likely Pathogenic
26
VUS
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
96
0
96
Likely Pathogenic
0
0
2
0
2
VUS
0
19
7
0
26
Likely Benign
0
0
0
0
0
Benign
0
0
1
0
1
Total0191060125

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RAB31 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →